On Monday, 8 October, the Stockholm-based Karolinska Institutet announced the award of the 2024 Nobel Prize in Physiology or Medicine jointly to American researchers Victor Ambros (b. 1953), professor of Natural Sciences at the University of Massachusetts Medical School, and Gary Ruvkun (b. 1952), principal investigator and professor of genetics at Massachusetts General Hospital and Harvard Medical School.
The achievement of these geneticists was the discovery of non-coding RNA molecules, microRNAs, which are involved in the regulation of gene expression in the small nematode worm Caenorhabditis elegans. Although this finding, made in the 1980s, was initially of no interest, its value has grown over time, since microRNAs are regulators of the gene activity found in all organisms, from single-celled prokaryotes, such as Archaea and Bacteria, to the most evolved multicellular eukaryotes, such as plants and animals, including man.
Regulation of gene expression prior to Ambros and Ruvkun
Genes are units of genetic information based on DNA molecules. This information is passed from cell to cell and from parent to child in all species. In cases of sexual reproduction, fertilization marks the beginning of life and, after formation of the zygote, embryonic development begins. The organism grows through cell divisions preceded by DNA replication.
The entire development process is genetically regulated in space and time, so that, although all the cells conserve the same genetic information of the initial zygote, the lineages of each cell are determined towards their differentiation, which will eventually be reflected in the specialty of one tissue or another, depending on the genes that are activated. In the case of man, specialization is accentuated after implantation, in the gastrula state, from day 5 after fertilization. When the time comes, only a few genes are expressed in each cell type, while the others remain inactive. This means that there are regulatory mechanisms of genetic activity so that, at each time and place in the developing organism, only the correct set of genes is expressed. i.e., when it is time, only the genes that determine the specialized functions of each developing tissue or organ are expressed. How is this possible? The first insights into the mechanisms of genetic regulation emerged in the 1960s.
First, it was discovered that DNA information from genes flows by generating a copy of the message in the form of a messenger RNA molecule, mRNA, through a process called “transcription”. Then, through the use of cellular machinery, its message is translated into the synthesis of a protein, a process known as “translation”. In this way, proteins are made according to the instructions of genes mediated by mRNA molecules.
The next step was taken in the 1960s, when the first regulatory mechanism of gene expression was discovered, through beautiful experiments with bacteria carried out by the French molecular biologists François Jacob (1920-2013) and Jacques Monod (1910-1976), winners of the 1965 Nobel Prize in Medicine.
What Jacob and Monod discovered in prokaryotes relates to the action of some “transcription factors”, proteins that bind to DNA upstream of the gene’s coding region, the so-called “promoter”, allowing or blocking access of the enzyme RNA polymerase for mRNA synthesis. These mechanisms are more complex in eukaryotes, but they are essentially based on the same thing. Gene expression depends on transcription factors that bind to gene promoters to enable, stimulate, inhibit, or block mRNA synthesis. To this are added other epigenetic factors, such as the state of condensation or relaxation of the chromosomal region of the gene. For a gene to be expressed there must be relaxation of the region of the chromosome in which it is found, which will facilitate the access of transcription factors and enzymes involved in it.
Ambros and Ruvkun’s microRNAs
Over the years, thousands of transcription factors have been identified, and it was believed that the basic principles of gene regulation had been solved with the mechanism discovered by Jacob and Monod. In the 1980s, however, the now award-winning researchers would discover a new mechanism that is added to the previous one and that operates on the mRNA after transcription. The discovery was made in the nematode worm Caenorhabditis elegans, which, despite its simplicity and small size, has become an animal model of great importance in genetic and neurological research. It has many types of specialized cells (muscle, nerve cells, etc.) just like larger and more complex animals, so it allows scientists to investigate how tissues develop and mature in multicellular organisms.
Briefly, Ambros and Ruvkun were studying the C. elegans mutant strains lin-4 and lin-14. Ambros had shown that lin-4 appeared to be a negative regulator of lin-14, and that said gene encoded a tiny RNA, microRNA, that could not be translated into protein but which appeared to interfere with the expression of lin-14. Ruvkun isolated and cloned the lin-14 gene, and both scientists found that the lin-4 microRNA sequence matched a complementary sequence in the lin-14 mRNA. The conclusion they reached is that inhibition of lin4 to lin14 is not exerted on the gene, but on the product of its transcription, the mRNA, after it has been expressed. Regulation seemed to occur at a later stage of the gene expression process, not by blocking transcription, but by blocking translation.
In this way, a hitherto unknown type of RNA molecule, microRNA, became a new way of regulating gene expression. The results were published in 1993 in two articles in the journal Cell [1.2]. However, it took another discovery to gain acceptance of this new mechanism of gene action in the world of Molecular Genetics.
Several years later, we know that different families of about 50,000 microRNA genes have been detected in the human genome, capable of acting as regulators of gene expression by interfering with different target mRNAs of thousands of genes. It is actually a universal mechanism of multicellular organisms. We also understand how microRNAs are synthesized from the genes of the cell nucleus and how they are processed by enzymes that enable them to act on the target mRNAs. We know from genetic research that the cells and tissues of multicellular organisms need microRNAs for their development and specialization. Epigenetic regulators can be considered in the sense of affecting the expression levels of the genes encoding the target mRNAs, without modifying their genetic sequences. In turn, however, the microRNAs’ own coding genes can be regulated by epigenetic modifications, including DNA methylation and histone modifications. Thus, the reciprocal actions of microRNAs and the epigenetic pathway appear to complement each other and participate in the expression of genes that determine cell differentiation during development.
The genes encoding microRNAs are longer than the active end product, requiring pre-action processing. This happens as follows: the gene is transcribed to give a long RNA molecule that folds into a loop due to the base complementarity of much of the molecule. This double-stranded primary microRNA undergoes a loss at both ends, thanks to the action of the enzyme DROSHA, and takes place inside the cell nucleus. The shorter product then moves from the nucleus to the cytoplasm and, after the action of another enzyme called DICER, is fragmented and reduced to about 18-25 single-chain bases, while the other is lost. The end product is the microRNA already processed and prepared to recognize the target mRNA, on which it acts by complementing the bases, interfering and blocking its translation.
Recent research has shown that abnormal regulation by microRNA may cause cancer, and that in the human genome there are mutations in the genes coding for microRNAs that can cause a number of diseases such as congenital hearing loss, eye and skeletal disorders, etc. Mutations in the gene that codes for the DICER enzyme — necessary for microRNA processing — result in DICER syndrome, a rare disease related to several types of cancer.
Finally, it should be noted that Ambros and Ruvkun’s discovery broadens our understanding of the processes that explain the fine-tuning of gene expression that determines cell differentiation during the development and specialization of cells and tissues in multicellular organisms.
Nicolás Jouve
Professor Emeritus of Genetics at the University of Alcalá
Member of the Bioethics Observatory
Former member of the Spanish Bioethics Committee
REFERENCES